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Current tissue engineering techniques are limited by inadequate vascularisation and perfusion of cell-scaﬀold constructs.
Microstructural patterning through biomimetic vascular channels within a polymer scaﬀold might induce neovascularization,
allowing fabrication of large engineered constructs. The network of vascular channels within a frontal-parietal defect in a
patient, originating from the anterior branch of the middle meningeal artery, was modeled using computer-aided design (CAD)
techniques and subsequently incorporated into polycaprolactone (PCL) scaﬀolds fabricated using fused deposition modeling
(FDM). Bone marrow-derived mesenchymal stem cells (MSCs) were seeded onto the scaﬀolds and implanted into a rat model,
with an arteriovenous bundle inserted at the proximal extent of the vascular network. After 3 weeks, scaﬀolds were elevated
as a prefabricated composite tissue-polymer flap and transferred using microsurgical technique. Histological examination of
explanted scaﬀolds revealed vascular ingrowth along patterned channels, with abundant capillary and connective tissue formation
throughout experimental scaﬀolds, while control scaﬀolds showed only granulation tissue. All prefabricated constructs transferred
as free flaps survived and were viable. We term this concept “vascular guidance,” whereby neovascularization is guided through
customized channels in a scaﬀold. Our technique might potentially allow fabrication of much larger tissue-engineered constructs
than current technologies allow, as well as allowing tailored construct fabrication with a patient-specific vessel network based on
CT scan data and CAD technology.
1. Introduction
A major limitation in clinical translation of tissue engi-
neering techniques remains inadequate vascularisation, and
hence perfusion of cell-scaﬀold constructs. In many studies
using polymeric scaﬀolds in bone tissue engineering, tissue
formation has been confined to the area immediately
underneath the surface of the construct due to poor media
perfusion of cells in the depths of the scaﬀold, resulting in
impaired delivery of nutrients and growth factors, as well as
hypoxia due to poor oxygenation.
An early study with poly-L-glycolic acid (PLGA) foams
found that the penetration depth of osseous tissue was
restricted to 190–220 μm from the surface of a tissue-
engineered construct [1]. Subsequent strategies utilising
bioreactors [2] and material modifications incorporating
hydroxyapatite into polymer scaﬀolds [3] resulted in pen-
etration depths of 3.7 mm and 1.4 mm, respectively. With
the use of novel biomimetic scaﬀold architectures such as
one mimicking trabecular bone [4], tissue reaching a depth
of 10 mm was engineered. Most recently, our group and
others reported the use of fused deposition modeling (FDM),
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Figure 1: (a) Three-dimensional reconstruction of skull defect
based on computed tomography (CT) scans of a patient who had
a right frontoparietal craniectomy. (b) The arborizing course of the
anterior branch of the middle meningeal artery can be observed on
the internal aspect of the bone flap, providing a model for design of
vascular channels.
(a) (b)
(c) (d)
Figure 2: CAD model of design for vascular channels, with
predicted pattern of blood flow. The model predicts orderly blood
flow proceeding proximally from the source vessel to distal channels
in a symmetric fashion.
a rapid prototyping technique, to engineer geometrically
symmetric polycaprolactone (PCL) scaﬀolds with complete
interconnectivity, allowing for osseous tissue formation
throughout the entire cell-scaﬀold construct [5–7].
While these techniques might allow tissue formation
throughout the entire extent of a small polymeric scaﬀold,
they would not be suﬃcient to ensure adequate perfusion of
a large tissue-engineered construct, which would be required
for the vast majority of clinical applications. Examples
5 mm
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Figure 3: Fabricated PCL scaﬀold with incorporated vascular
channels in arborizing pattern following an open channel design,
based on course of middle meningeal artery in the calvarium. (a)
Top view. (b) Red markings show branching vascular channels. (c)
Side view.
of these include a calvarial bone flap for cranioplasty, or
an engineered long bone segment to replace segmental
extremity defects.
We postulated that microstructural patterning through
creation of biomimetic vascular channels following an open
channel design within the polymer scaﬀold might allow nat-
ural inductive neovascularization, thereby creating a scaﬀold
allowing excellent perfusion in its entirety. As a result, large
complex engineered cell-scaﬀold constructs could potentially
be created, representing a major step forward towards clinical
application of bone tissue engineering techniques. For our
clinical model, we chose the calvarial bone flap model.
2. Materials and Methods
2.1. Conceptualization and Design of Vascular Channels. The
frontal-parietal bone flap elevated in a standard craniectomy
results in a significant skull defect (Figure 1(a)). On the
internal aspect of the bone flap, grooves caused by the
middle meningeal artery can be seen (Figure 1(b)), which
arborize in a branching pattern to perfuse the calvarium,
together with the anterior and posterior meningeal arteries.
Due to limitations of the computer-aided design (CAD)
software used, only 3 factors could be edited for design
of the vascularization pattern, which included the angle of
branching, channel diameter, and space between tubes.
Through analysis of the arborization pattern of the
middle meningeal artery, we arrived at several rules and
assumptions for design of vascular channels in our scaﬀold.
These include the following: (1) angle of branching of
channels should be around 45 degrees; (2) channel diameter
was set at 1 mm due to mechanical constraints and ease
of fabrication; (3) spacing between tubes was set at 1 mm.
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Figure 4: Rat groin model for investigation of vascular guidance. (a) Inferior epigastric vessels are isolated and ligated. (b) Inferior epigastric
vascular pedicle is inserted into the proximal egress into the vascular channel network and secured with suture.
(a) (b)
Figure 5: Explanted scaﬀolds after 3 weeks in vivo in rat groin model were transferred as composite tissue-polymer-free flaps to the neck.
(a) End-to-side anastomosis of inferior epigastric artery to the common carotid artery (white marker). Inferior epigastric vein was also
anastomosed in end-to-side fashion to the internal jugular vein. (b) After surgery with flap inset.
Spacing between capillaries in the human body has been
reported to be 200 μm, with a capillary diameter of around
50 μm. Fabrication of scaﬀolds with a physiological channel
spacing of 200 μm would result in compromised mechanical
strength, hence a tube spacing of 1 mm was used instead.
The Pro/ENGINEER software (Parametric technology cor-
poration, Needham, MA) was used to create a CAD model of
the scaﬀold, together inclusive of vascular channels. Figure 2
shows the resultant CAD model used for fabrication of
vascular channels with the predicted blood flow pattern.
2.2. Fabrication of Polymer Scaﬀolds. Poly-e-caprolactone
(PCL) of molecular weight (Mn) 80,000 (Sigma-Aldrich)
was used, together with hydroxyapatite (HA), in a 9 : 1
ratio. The PCL-HA scaﬀolds were fabricated using fused
deposition modeling (FDM), a rapid prototyping process, as
previously described [8]. For this study, scaﬀolds measuring
18 × 18 × 3 mm were fabricated with a filament laydown
pattern of 0, 60, and 120 degrees, and a porosity of 70%.
Figure 3(a) shows the top view of the fabricated scaﬀold,
with red markings showing the branching vascular channels
(Figure 3(b)). Figure 3(c) shows the side view of the scaﬀold,
with channel diameter of 1 mm.
2.3. Cell Isolation and Culture—Preparation of Scaﬀolds.
Porcine bone-marrow-derived mesenchymal stem cells
(MSCs) were harvested using standard protocols [9]. Cells
used were at passage two and maintained in complete
DMEM + GlutaMAX I (Gibco, USA) [10%FBS + 1%
Pen/Strep]. Cultures were passaged once a week and media
changed every three days.
Prior to cell seeding, scaﬀolds were washed with
phosphate-buﬀered saline (PBS) and sterilized with 70%
ethanol. Subsequently, scaﬀolds were seeded with an MSC-
fibrin glue suspension. MSCs at a density of 1 × 106
cells were initially suspended in fibrinogen (Tisseel, Baxter
Biosciences, Germany) and then seeded homogenously onto
PCL scaﬀolds. Thrombin was added to polymerize the
mixture and create a fibrin glue simulating the extracellular
matrix around cells.
2.4. Animal Surgery and Histological Analysis. A 2 cm inci-
sion was made in the right groin of adult male immunode-
ficient CBH-ruul/+ nude rats, following which the inferior
epigastric artery and vein were dissected out and ligated
en masse (Figure 4(a)). The vascular pedicle thus created
was then inserted into the proximal opening of the vascular
channel network in the experimental scaﬀold (which had
been previously seeded with MSCs) and secured with 4-
0 Prolene (Ethicon, Sommerville, NJ) (Figure 4(b)). The
scaﬀolds were then placed in a subcutaneous groin pocket,
and the wound closed in layers. Control scaﬀolds were
identical to experimental scaﬀolds in size, material, and
laydown pattern and had MSCs seeded at the same density.
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Figure 6: (a) Experimental scaﬀolds explanted after 3 weeks in vivo show evidence of blood vessel formation (red, marked ∗) with
surrounding connective tissue (blue areas). These areas together represent a vascular channel that was prefabricated within the PCL-HA
scaﬀold. Clear areas occupied by surrounding PCL-HA scaﬀold fibers are marked with an “X”. (b) Multiple capillaries (red, marked with ∗)
are also seen in areas of connective tissue, indicating extensive neovascularization. (c) In contrast, control scaﬀolds only show granulation
tissue without evidence of significant neovascularization.
Figure 7: Customized scaﬀold design with a patient-specific vascu-
lar network using computer-aided design (CAD) techniques based
on three-dimensional CT data allows modeling and fabrication of
a tailored construct. CAD model shown here is tailored to the
dimensions and shape of the calvarial defect and also is able to
simulate the vessel network in the defect.
However, these were placed in the contralateral groin without
ligation or implantation of the inferior epigastric pedicle.
Animals (n = 5) were sacrificed after 3 weeks, and specimens
explanted for histological analysis with hematoxylin and
eosin (H&E) staining.
To investigate the hypothesis that the prefabricated
scaﬀold constructs could be transferred via microsurgical
technique as a free flap after 3 weeks in vivo, some of
the explanted specimens (n = 3) were raised en bloc as
part of a composite osteocutaneous-scaﬀold groin flap based
on the inferior epigastric vessels. The inferior epigastric
artery was then anastomosed using 10-0 Prolene (Ethicon,
Sommerville, NJ) sutures via end-to-side technique to the
common carotid artery (Figure 5(a)), while the inferior
epigastric vein was anastomosed end-to-side to the internal
jugular vein. The flap was inset into the scalp of the rat
(Figure 5(b)).
Housing and feeding of the animals were done in
accordance with standard animal care protocols. The study
was approved by the Animal Welfare Committee, National
University of Singapore and licensed by the National Insti-
tutes of Health’s (NIH) Guide for the Care and Use of
Laboratory Animals.
3. Results
H&E staining of experimental scaﬀolds 3 weeks after implan-
tation showed formation of blood vessels in the vascular
channels following the microstructural arborization pattern
of the scaﬀold (Figure 6(a)), surrounded by connective
tissue. In addition, there was evidence of angiogenesis in the
connective tissue, with formation of multiple capillaries (Fig-
ure 6(b)). Angiogenesis was seen throughout the construct,
permeating throughout the connective tissue. In contrast, for
the control scaﬀolds, only granulation tissue was observed
without evidence of neovascularization (Figure 6(c)).
Following transfer of prefabricated composite tissue-
polymer groin flaps to the neck, the flaps were observed to be
viable as observed clinically by good perfusion and capillary
refill, as well as dopplerable arterial and venous signals.
4. Discussion
A piece of tissue with a volume exceeding a few cubic
millimeters cannot survive by diﬀusion of nutrients but
requires growth of capillaries for the supply of essential
nutrients and oxygen [10]. Correspondingly, when a cell is
more than 150–200 μm from a blood vessel, it suﬀers from
hypoxia and limitation of other nutrients because this is
the maximum distance it can stay alive by diﬀusion only
[11]. For tissue engineering to progress to widespread clinical
application, therefore, creation of a microvascular network
of capillaries and supporting macrovascular circulation is
essential to support perfusion of large complex tissues and
whole organs.
Early studies on flap prefabrication were focused on
inducing formation of an intrinsic vascular supply in a
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block of tissue through staged microvascular transfer, in
order to improve survival [12, 13]. However, reports of
venous insuﬃciency following second-stage transfer as well
as the technical complexity of these procedures have limited
widespread use of prefabricated free flaps [14]. Subsequent
eﬀorts have been focused more on achieving vascularisation
in in vitro models. These have included the use of an
arteriovenous bundle, as was used in this study; or an
arteriovenous loop to induce the formation of a network of
vessels for prefabrication of skin flaps [15, 16].
In many of these studies, a vascularized chamber was
used to study induction of tissue formation. In a diﬀerent
experimental context of an in vivo plastic chamber housing
a poly (DL-lactic-co-glycolic acid) (PLGA) scaﬀold, vas-
cularized tissue formation [17, 18] or adipose tissue [19]
was induced by implantation of an arteriovenous loop.
Organ patterning, such as fabrication of a parenchymal
chamber modeled upon hepatic organ architecture for use
as a liver-assist device, has also been reported [20]. In
this study, computational models were used to study flow
behaviour in human microvasculature, subsequent to which
a conceptual device was fabricated. Most recently, the use
of three-dimensional computed tomography (CT) scanning
and CAD techniques has been used to prefabricate an
osseocutaneous flap for autogenous mandible reconstruction
using the latissimus dorsi muscle as a vascularized carrier for
free tissue transfer [21].
Extending the use of an arteriovenous bundle fur-
ther via the fabrication of customized vascular channels
through microstructural scaﬀold patterning, together with
the use of computational analysis and CAD fabrication of
vessel channels, as was done in this study, allows highly
accurate fabrication of a biomimetic scaﬀold potentially
allowing prefabrication of large composite osseous-polymer
or osteocutaneous-polymer flaps. These could be transferred
through microsurgical technique as free flaps with applica-
tion in reconstructive surgery.
While the results in this study are still preliminary,
we show that inductive neovascularization through scaﬀold
fabrication techniques is achievable. Hence, this technique,
which we would term “vascular guidance,” whereby neo-
vascularization is guided through customized channels in
a scaﬀold, might potentially allow fabrication of much
larger tissue-engineered constructs than current technologies
allow. Our technology also allows fabrication of customized
scaﬀolds with a patient-specific vessel network, allowing tai-
lored construct fabrication based on CT scan data (Figure 7).
In previous studies, we defined the concept of “cell guid-
ance” [22, 23], whereby a biomimetic environment is created
through constant delivery of cytokines to diﬀerent areas of
an implanted scaﬀold, so as to allow site-specific homing of
cells for purposes of total in vivo tissue engineering. Both
“vascular guidance” and “cell guidance” would fall under the
concept of “biological guidance,” which we define here as “a
therapeutic approach for channeling specific biologic events
by directing and orchestrating cellular mediators and factors
in order to achieve in vivo tissue regeneration.” “Biological
guidance” represents a shift from current thinking in tissue
engineering and organ regeneration but would potentially
represent a major step towards clinical translation of tissue
engineering techniques.
In conclusion, we show in this proof-of-principle experi-
ment that inductive neovascularization through microstruc-
tural scaﬀold patterning provides a new technique for poten-
tially engineering large cell-scaﬀold constructs for tissue and
organ regeneration, in addition to providing the capability
for facilitating reconstructive surgery through free tissue
transfer.
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